Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Chloroquine phosphate
Drug ID BADD_D00441
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D02125
MeSH ID C023676
PubChem ID 64927
TTD Drug ID D09EGZ
NDC Product Code 50090-4967; 64980-177; 68022-7057; 73377-214; 0115-2790; 68022-0264; 76385-142; 0115-7010; 64980-178; 62135-717; 57451-1116; 73377-028; 68022-0265; 23155-850; 63850-8080
UNII 6E17K3343P
Synonyms chloroquine diphosphate | chingamin phosphate | N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine, phosphate (1:2) | delagil | khingamin phosphate | unspecified phosphate of chloroquine diphosphate | arechin | chloroquine phosphate | Resochin | chloroquine diphosphate, (+-)-isomer | chloroquine diphosphate, (-)-isomer | chloroquine bis(dihydrogenphosphate) dihydrate | chloroquine diphosphate, (+)-isomer
Chemical Information
Molecular Formula C18H32ClN3O8P2
CAS Registry Number 50-63-5
SMILES CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pancytopenia01.03.03.003--Not Available
Personality change19.05.01.006; 17.02.05.019--
Photosensitivity reaction23.03.09.003--
Polyneuropathy17.09.03.012--Not Available
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Seizure17.12.03.001--
Sensory disturbance17.02.07.006--Not Available
Skin exfoliation23.03.07.003--Not Available
Stevens-Johnson syndrome10.01.01.045; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Thrombocytopenia01.08.01.002--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Urticaria23.04.02.001; 10.01.06.001--
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.10.013--Not Available
Vomiting07.01.07.003--
Hypoacusis04.02.01.006--
Hepatic enzyme increased13.03.04.028--Not Available
Electrocardiogram change13.14.05.014--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Psychotic disorder19.03.01.002--
Pigmentation disorder23.05.03.001--Not Available
Lichenoid keratosis23.01.01.004--Not Available
The 2th Page    First    Pre   2    Total 2 Pages